L’Initiative L’Initiative
  • L'Initiative
  • Our priorities

      Our priorities

    • HIV/AIDS
    • Tuberculosis
    • Malaria
    • HPV and cervical cancer
    • Gender and human rights
    • Community health
    • Operational Research and Science
    • Human resources for health
  • How we work

      How we work

    • Catalytic project funding
      • Is your project eligible for support?
      • Apply for a call for proposals
      • Explore the projects we support
    • Mobilizing technical expertise
      • Request technical assistance
      • Experts, join us!
    • Addressing overlooked challenges
    • Strengthening civil society capacities
    • Supporting operational research and innovation
    • Learning and improving through evaluation and knowledge-sharing
  • News
  • Resources
    • fr
    • en
  • L'Initiative
  • Our priorities
    • HIV/AIDS
    • Tuberculosis
    • Malaria
    • HPV and cervical cancer
    • Gender and human rights
    • Community health
    • Operational Research and Science
    • Human resources for health
  • How we work
    • Catalytic project funding
      • Is your project eligible for support?
      • Apply for a call for proposals
      • Explore the projects we support
    • Mobilizing technical expertise
      • Request technical assistance
      • Experts, join us!
    • Addressing overlooked challenges
    • Strengthening civil society capacities
    • Supporting operational research and innovation
    • Learning and improving through evaluation and knowledge-sharing
  • News
  • Resources
Recherche
Home > Resources > Policy brief – The malaria vaccine: promising progress, but not a silver bullet
En The Malaria Vaccine Promising Progress But Not A Silver Bullet

Policy brief – The malaria vaccine: promising progress, but not a silver bullet

11 November 2021

Following the WHO announcement recommending a vaccine for children at risk of contracting malaria, this L’Initiative policy brief provides analysis and insight into understanding this first ever malaria vaccine (known as RTS,S).

Malaria

Documents to download

Policy brief - The malaria vaccine promising progress but not a silver bullet (0.55 Mo)

Read also

Vignette Do Insecticides Have The Same Effectiveness Against. 0
01 · 01 · 2017
Do insecticides have the same effectiveness against infectious and noninfected mosquitoes?
Read the article
Do insecticides have the same effectiveness against infectious and noninfected mosquitoes?
Focus
25 · 04 · 2023 HIV/AIDS Malaria +1
Strengthening the role of community health workers in the Greater Mekong Region
Actualité Read the article
Strengthening the role of community health workers in the Greater Mekong Region
Editorial Piece
29 · 07 · 2022 HIV/AIDS Malaria +1
Ten years of responding to field needs
Actualité Read the article
Ten years of responding to field needs
Editorial Piece
16 · 06 · 2022 Cross-cutting HIV/AIDS +2
Global health, a decisive year
Actualité Read the article
Global health, a decisive year
Broad View
19 · 06 · 2025 Cross-cutting
Leaving no child or adolescent in the response
Actualité Read the article
Leaving no child or adolescent in the response
Cover Cross-cutting Evaluation - Health Community
09 · 12 · 2025
Cross-cutting Evaluation – Health community
Read the article
Cross-cutting Evaluation – Health community
Article
27 · 01 · 2023 Cross-cutting HIV/AIDS +2
Global Fund 7th Replenishment Cycle: the experts are ready!
Actualité Read the article
Global Fund 7th Replenishment Cycle: the experts are ready!
Interview
21 · 04 · 2022 HIV/AIDS Malaria
Malaria: antimalarial and antiparasitic resistance
Actualité Read the article
Malaria: antimalarial and antiparasitic resistance
Focus
19 · 04 · 2021 HIV/AIDS Malaria
Strengthening health systems through operational research
Actualité Read the article
Strengthening health systems through operational research
Impact Of Sunlight Exposure On The Residual Efficacy Of
01 · 01 · 2019
Impact of sunlight exposure on the residual efficacy of biolarvicides Bacillus thuringiensis israelensis and Bacillus sphaericus against the main malaria vector, Anopheles gambiae
Read the article
Impact of sunlight exposure on the residual efficacy of biolarvicides Bacillus thuringiensis israelensis and Bacillus sphaericus against the main malaria vector, Anopheles gambiae
Back to the list

La Nouvelle Initiative

Sign up to receive our newsletter

Subscribe to our newsletter

I have taken note of the Terms and conditions of use

Implemented by:

Funded and placed under the supervision of:

As part of the French contribution to:

Quick access
How to request technical assistance ? Our calls for proposals Our documentary resources Experts, join us! Legal notice Privacy policy
Contact

Expertise France – The Initiative
40, boulevard de Port-Royal
75005 Paris, France

Follow us
X
Our news Flux RSS
©Expertise France – 2025
Ce site est protégé par le reCAPTCHA Google.
Politique de confidentialité et conditions d’utilisations.
Agence Ecommerce Rennes

Outils d'accessibilité

  • Taille du texte :
  • Haut contraste
  • Liens soulignés
  • Police lisible
  • Police dyslexique